COMPANY HISTORY

  • 2004: 3 years R&D for konjac sponges, apply for patents and start mass production; cosmetic tools in Japanese drugstore.

  • 2007: Open Asia market, cooperate with Fuji group in Japan, named No.1.

  • 2010: Register Bebevisa trademark, expand the global market.

  • 2012: Open EU and USA market, become supplier of Unilever and P&G.

  • 2015: 5000m² GMPc workshop and 33,334m² rose farm, setup joint ventures in Guangzhou, HK, USA.

  • 2017: Obtain 20 million financing, production licenses of cosmetics, disinfection products.

  • 2018: New innovative product lines on konjac mask/eyepatches/wipes/towels. Konjac mask into the global market, ready for Chinese brand operation.

  • 2019: Establish online and offline sales channels, production licenses of medical device products.

  • 2020: Founded SAS Bebevisa Naturlias France.

  • 2021: Focus on R&D of functional ingredients with natural plant; Aim to OEM/ODM, optimize service process; Commit to creating a one-stop purchasing service platform.

COMPANY INTRODUCTION

Wuhan Pibei Weisha Biotechnology Co., Ltd., established in 2012, is a comprehensive biotechnology enterprise integrating R&D, production, and sales. The company specializes in konjac-based biodegradable materials and is recognized as a National High-Tech Enterprise and a Wuhan East Lake High-Tech Zone Gazelle Enterprise.In 2017, the company secured RMB 20 million in funding, enabling a comprehensive upgrade of its R&D and production facilities, along with the implementation of the UFIDA U8+ RFID management system.

 

Located in the Wuhan Optics Valley Bio-City, the company operates a 5,000㎡ GMPC-certified production facility and 40,000㎡ of warehouse space, supported by fully equipped R&D and testing laboratories. The annual production capacity reaches 30 million konjac facial mask sheets and 10 million konjac sponges.

With extensive experience in international trade, all self-developed konjac-based products are protected by national invention patents. The products are exported to 76 countries worldwide, with total sales exceeding 50 million units. They meet both EU and FDA export standards and hold an 80% market share in the global konjac sponge category.